Credit Suisse’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $836K | Buy |
|
|||||
|
2023
Q2 | $785K | Buy |
|
|||||
|
2023
Q1 | $536K | Buy |
|
|||||
|
2022
Q4 | $339K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $692K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $225K | Sell |
|
|||||
|
2021
Q2 | $568K | Buy |
|
|||||
|
2021
Q1 | $556K | Buy |
|
|||||
|
2020
Q4 | $719K | Sell |
|
|||||
|
2020
Q3 | $680K | Sell |
|
|||||
|
2020
Q2 | $1.18M | Buy |
|
|||||
|
2020
Q1 | $774K | Sell |
|
|||||
|
2019
Q4 | $2.16M | Buy |
|
|||||
|
2019
Q3 | $402K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $302K | Sell |
|
|||||
|
2016
Q2 | $212K | Buy |
|
|||||
|
2016
Q1 | $186K | Sell |
|
|||||
|
2015
Q4 | $205K | Buy |
|